SpeeDx to Feature PlexPCR(TM) and ResistancePlus(TM) Tests on M. genitalium at ECCMID
08 avr. 2016 13h17 HE
|
SpeeDx Pty, Ltd.
SYDNEY, AUSTRALIA--(Marketwired - Apr 8, 2016) - SpeeDx Pty, Ltd. today announced that it will feature its PlexPCR™ for detection of infectious disease pathogens and the unique...
SpeeDx Announces Distribution Agreement for PlexPCR(TM) and ResistancePlus(TM) Molecular Diagnostics Products With Goffin Molecular Technologies
04 avr. 2016 09h00 HE
|
SpeeDx Pty, Ltd.
SYDNEY, AUSTRALIA--(Marketwired - Apr 4, 2016) - SpeeDx Pty, Ltd. today announced a distribution agreement with Goffin Molecular Technologies B.V., a molecular diagnostic company based in the...
Retrotope Advances RT001 in Clinical Trials to Treat Friedreich's ataxia
22 févr. 2016 09h00 HE
|
Retrotope
LOS ALTOS, CA--(Marketwired - Feb 22, 2016) - Retrotope, a privately held clinical stage pharmaceutical company, today announced the successful completion of the first dose cohort and the opening...
e-Vision Accelerates Development Program for First Fully Tunable Electronic Contact Lens
12 nov. 2015 14h05 HE
|
e-Vision
LAS VEGAS, NV--(Marketwired - Nov 12, 2015) - E-Vision Smart Optics, Inc., a Sarasota-based company specializing in electrically-modulated tunable lens technology, announced today that it is...
Transcend Medical Announces 12-Month European Study Results of the CyPass Micro-Stent(R) at AAO 2012
13 nov. 2012 13h00 HE
|
Transcend Medical
CHICAGO, IL--(Marketwire - Nov 13, 2012) - Transcend Medical, Inc., an ophthalmic device company dedicated to developing minimally invasive glaucoma therapies, announced the 12-month results of the...
Transcend Medical Launches the Transcend Vold Gonio Lens (TVG) for Improved Visualization During Micro-Invasive Glaucoma Surgery
12 nov. 2012 09h00 HE
|
Transcend Medical
CHICAGO, IL--(Marketwire - Nov 12, 2012) - Transcend Medical, Inc., an ophthalmic device company dedicated to developing minimally invasive glaucoma therapies, today announced the commercial...
Transcend Medical Announces Four Scientific Abstracts at the American Society of Cataract and Refractive Surgery Annual Meeting
21 avr. 2012 09h00 HE
|
Transcend Medical
CHICAGO, IL--(Marketwire - Apr 21, 2012) - Transcend Medical, Inc., an ophthalmic device company dedicated to developing minimally invasive glaucoma therapies, announced that the CyPass...
Sunshine Heart Announces Results of Its C-Pulse(R) Feasibility Trial at the Transcatheter Cardiovascular Therapeutics Conference
07 nov. 2011 08h00 HE
|
Sunshine Heart, Inc.
SYDNEY, AUSTRALIA and EDEN PRAIRIE, MN--(Marketwire - Nov 7, 2011) - Sunshine Heart, Inc. (ASX: SHC), a global medical device company focused on innovative technologies for moderate to severe heart...
Sunshine Heart's Feasibility Trial Outcomes to Be Presented at Transcatheter Cardiovascular Therapeutics Conference
19 oct. 2011 05h00 HE
|
Sunshine Heart, Inc.
SYDNEY, AUSTRALIA and EDEN PRAIRIE, MN--(Marketwire - Oct 19, 2011) - Sunshine Heart, Inc. (ASX: SHC), a global medical device company focused on innovative technologies for moderate heart failure,...
Sunshine Heart Appoints New US Board Member
03 août 2011 15h19 HE
|
Sunshine Heart, Inc.
SYDNEY, AUSTRALIA and EDEN PRAIRIE, MN--(Marketwire - Aug 3, 2011) - Sunshine Heart, Inc. (ASX: SHC), a global medical device company focused on innovative technologies for moderate heart failure,...